News

The patient-partnered initiative will enable anyone in the USA and Canada affected by osteosarcoma to participate.

The clinical trial will investigate the effectiveness of a combination of two oral drugs targeting the DNA damage response pathway.

Dr. Baird specializes in the care of children with neurological disorders of the brain and spine, with specific expertise in brain and spinal cord tumors, cerebrovascular malformations, and skull base neurosurgery.

Daphne Haas-Kogan, of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, will receive a research grant totaling $600,000 over three years for “Dependence of DIPGs on DNA polymerase q for DNA repair defines a new therapeutic target.”

Launched by the King Faisal Foundation (KFF) and granted for the first time in 1979, the King Faisal Prize (KFP) recognizes the outstanding works of individuals and institutions in five major categories: Service to Islam, Islamic Studies, Arabic Language and Literature, Medicine, and Science.

Boston magazine has named at least 25 faculty members of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center to its annual "Top Doctors" guide.

One of ASH’s most prestigious research award programs, the ASH Scholar Awards financially support fellows to junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators.

Earlier this month, diffuse intrinsic pontine glioma (DIPG) researchers from several pediatric hospitals around the country gathered in Boston to share their innovative ideas.

The Doris Duke Charitable Foundation announced the six projects receiving approximately $5 million through the second Sickle Cell Disease/Advancing Cures grant competition.

The peptides, folded into specific three-dimensional shapes using chemical “staples” for reinforcement, kill multidrug resistant bacteria but don’t harm red blood cells or other normal tissues.